当前位置:主页 > 医学论文 > 泌尿论文 >

TRB3在糖尿病肾病肾小管细胞中的表达及意义

发布时间:2018-08-11 21:44
【摘要】:研究背景与研究目的 糖尿病肾病(DN)是糖尿病(DM)最常见和最严重的并发症之一,据统计有30%的糖尿病患者会发展成为终末期肾病,所以研究它的发病机制就显得非常必要。长期以来,人们把研究的重点放在了肾小球损害上,但后来的研究显示肾小管的损伤在DN的发生发展中地位同等重要,因为研究发现糖尿病患者尿白蛋白排泄率还在正常范围时就已经存在肾小管损伤了。。肾小管损害包括肾小管上皮细胞肥大、凋亡,细胞外基质堆积等,其发病机制尚不完全明了。 Tribbles是Grosshan等在果蝇体内新发现的抑制有丝分裂的核基因,也被称为神经细胞死亡诱导蛋白激酶。TRB3是Tribbles的哺乳动物同源体TRB家族的一员,如该家族的其他成员一样,TRB3含有一个进化上较为保守的激酶样结构域,但是由于缺乏发挥催化活性的关键氨基酸残基和ATP结合位点,在现有的实验研究中都没有发现激酶活性。TRB3有广泛的生物学活性,包括可以增加胰岛素抵抗及调节细胞增殖等,并且在多个细胞转导通路中发挥作用,已知的有Akt通路,CDC25/String通路和MAPK通路。近期有研究报道TRB3沉默可以改善糖尿病大鼠的心肌纤维化,而Morse等发现TRB3在链脲菌素诱导的和自发的糖尿病小鼠肾脏中均表达增加,基于这些研究结果,我们假设TRB3同样参与了糖尿病肾病肾脏纤维化的发生。 凋亡被认为是糖尿病肾病发病机制的一个重要方面,因为它会导致肾脏体积的减少和功能的下降。目前的研究已经发现了糖尿病鼠模型和糖尿病病人肾脏标本中肾小管细胞凋亡的诸多证据,而TRB3与凋亡的关系一直是近年研究的热点,所以我们提出了TRB3可能参与了DN肾小管细胞凋亡的假设。 依据上述背景,本研究以链脲佐菌素(STZ)一次性腹腔内注射建立的糖尿病大鼠为模型研究TRB3在糖尿病大鼠肾脏中的表达及其与凋亡和纤维化的关系,并借助体外培养的肾小管上皮细胞进一步研究其作用机制。 研究方法 1.8周龄雄性Wistar大鼠80只,随机分为对照组30只和糖尿病组50只,糖尿病大鼠给予一次性腹腔注射STZ60mg/kg体重,对照组大鼠给予同等剂量柠檬酸钠缓冲液腹腔注射,于造模后8周、12周、16周及20周分别收集对照组与DM组大鼠(各7只)的血尿及肾组织进行各指标的检测。实验室方法检测各组大鼠的血糖、24h尿蛋白、血肌酐;PAS染色检测大鼠肾小球纤维化情况;免疫组织化学染色、荧光定量RT-PCR及western blot检测大鼠肾组织中TRB3、 fibronectin (FN)和Collagen Ⅰ (Col Ⅰ)的表达。造模12周后的糖尿病大鼠再随机分为糖尿病+空白病毒组(DM+vehicle组)和糖尿病+TRB3-siRNA病毒组(DM+TRB3-siRNA组)各10只,分别注射空白病毒和携带TRB3-siRNA的病毒,并于4周后处死留取肾脏测TRB3、FN和Col Ⅰ的表达。体外培养肾小管上皮细胞,用高糖及白蛋白刺激并检测TRB3的表达及FN和Collagen Ⅰ的分泌,用TRB3-siRNA将TRB3沉默后再次检测FN和Col Ⅰ的分泌以揭示其与TRB3的关系。 2.8周龄雄性Wistar大鼠40只,随机分为对照组(control组),糖尿病组(DM组),糖尿病+空白病毒组(DM+vehicle组)和糖尿病+TRB3-siRNA病毒组(DM+TRB3-siRNA组)各10只。糖尿病大鼠给予一次性腹腔注射STZ60mg/kg体重,对照组大鼠给予同等剂量柠檬酸钠缓冲液腹腔注射,造模16周后DM+vehicle组和DM+TRB3-siRNA组分别接受尾静脉注射空白病毒或携带TRB3-siRNA的病毒并于4周后处死。留取大鼠的肾组织检测TRB3的表达和凋亡情况。体外培养肾小管上皮细胞,用白蛋白刺激并检测TRB3的表达和凋亡情况,用TRB3-siRNA将TRB3沉默后再次检测凋亡的变化以揭示TRB3与凋亡的关系,并进一步探究Akt通路在此过程中的作用。 结果 1.TRB3介导糖尿病肾病肾小管细胞外基质聚积 1.1生化指标及组织学改变 STZ注射后,糖尿病大鼠的血糖明显升高,24h尿蛋白排泄量也明显增加,而血清肌酐清除率水平明显下降,肾肥大指数水平也明显高于正常组。PAS染色显示DN组大鼠的肾脏表现为系膜区明显的细胞外基质沉积,肾小球硬化(GS)水平较正常组明显升高。 1.2TRB3在糖尿病大鼠肾脏的表达增加 免疫组化结果显示对照组大鼠的肾脏基本不表达TRB3,而DM大鼠的肾脏则有较多TRB3阳性的细胞,并且定位于肾小管细胞,肾小球基本不表达。实时定量RT-PCR结果显示DM组TRB3mRNA表达明显高于对照组。Western blot结果显示TRB3蛋白在对照组表达量非常低,而在糖尿病组则表达明显升高。 1.3Col Ⅰ和FN的表达在糖尿病组明显升高,而TRB3沉默后则较前明显降低 TRB3沉默不影响24h尿蛋白排泄量。免疫组化和western blot的结果都表明Col Ⅰ和FN的表达在糖尿病组明显升高,而TRB3沉默后则明显降低。 1.4白蛋白可诱导NRK-52E细胞表达TRB3。 1.5白蛋白可诱导NRK-52E细胞分泌Col Ⅰ和FN,TRB3沉默后其分泌减少。 ELISA法检测Col Ⅰ和FN发现白蛋白可增加二者的分泌,而用TRB3-siRNA沉默TRB3的表达以后二者的分泌明显减少。 2.TRB3介导了糖尿病大鼠肾小管上皮细胞的凋亡 2.1TRB3在糖尿病大鼠肾脏的表达增加 免疫组化结果显示对照组大鼠的肾脏基本不表达TRB3,而DM大鼠的肾脏则有较多TRB3阳性的细胞,并且定位于肾小管细胞,肾小球基本不表达。实时定量RT-PCR结果显示DM组TRB3mRNA表达明显高于对照组。Western blot结果显示TRB3蛋白在对照组表达量非常低,而在糖尿病组则表达明显升高。 2.2糖尿病大鼠肾脏凋亡的测定及TRB3沉默对凋亡的影响 空白病毒的转染对大鼠肾脏TRB3的表达没有影响,而携带TRB3-siRNA的病毒转染大鼠后,TRB3在mRNA和蛋白水平的表达均明显降低。原位TUNEL测定结果显示对照组的阳性细胞数量很少,但是DM组的数量明显增加,且阳性细胞主要位于肾小管细胞,TRB3-siRNA转染后相对于空白病毒转染后TUNEL阳性细胞的数量明显降低。caspase活性检测也证明了这一点。 2.3白蛋白可诱导NRK-52E细胞表达TRB3。 用白蛋白刺激NRK-52E细胞,TRB3的表达随BSA浓度和刺激时间逐渐升高。 2.4白蛋白可诱导NRK-52E细胞凋亡,而TRB3沉默则可起一定的保护作用。 通过ssDNA ELISA法检测凋亡率结果显示白蛋白刺激细胞后凋亡细胞数明显升高,而将TRB3沉默后再用白蛋白刺激凋亡细胞数较之前明显下降,说明TRB3介导了此凋亡过程,caspase活性检测也证明了这一点。 2.5白蛋白通过使Akt磷酸化受阻从而引起凋亡,而TRB3沉默可部分逆转这一过程。 Akt通路是调节细胞凋亡的主要通路之一,白蛋白刺激使得磷酸化Akt/总Akt(p-Akt/Akt)降低,而用wortmannin阻断Akt磷酸化后,白蛋白导致的凋亡更加明显,说明Akt通路确实在此凋亡过程中发挥作用。将TRB3沉默以后,p-Akt/Akt明显升高,伴随着凋亡的减轻,说明Akt通路在TRB3诱导的凋亡过程中发挥作用。 结论 1.TRB3在糖尿病肾病肾小管细胞中的表达上调。 2.TRB3介导了糖尿病肾病肾小管细胞外基质Collagen Ⅰ和FN的分泌。 3.TPB3介导了糖尿病肾病肾小管细胞的凋亡过程。 4.TRB3基因沉默可改善糖尿病肾病肾小管细胞凋亡和细胞外基质堆积。
[Abstract]:Research background and research purpose
Diabetic nephropathy (DN) is one of the most common and serious complications of diabetes mellitus (DM). According to statistics, 30% of diabetic patients will develop end-stage renal disease, so it is necessary to study its pathogenesis. For a long time, people have focused on glomerular damage, but later studies have shown that renal tubular damage. It plays an important role in the occurrence and development of DN, because studies have found that renal tubular damage exists when the urinary albumin excretion rate of diabetic patients is within the normal range.
Tribbles is a newly discovered mitotic-suppressing nuclear gene, also known as neuronal death-inducible protein kinase, found in Drosophila by Grosshan et al. TRB3 is a member of the TRB family, a mammalian homologue of Tribbles. Like other members of the family, TRB3 contains an evolutionarily conserved kinase-like domain, but due to lack of it. The key amino acid residues and ATP binding sites that play a catalytic role have not been found in the existing experimental studies. TRB3 has a wide range of biological activities, including increasing insulin resistance and regulating cell proliferation, and plays a role in many cell transduction pathways, known as Akt pathway, CDC25/String pathway and M. Recent studies have reported that TRB3 silencing can ameliorate myocardial fibrosis in diabetic rats. Morse et al. found that TRB3 expression increased in the kidneys of streptozotocin-induced and spontaneous diabetic mice.
Apoptosis is considered to be an important aspect of the pathogenesis of diabetic nephropathy, because it leads to the decrease of renal volume and function. Therefore, we propose that TRB3 may be involved in the hypothesis of apoptosis of DN renal tubular cells.
Based on the above background, the expression of TRB3 in the kidneys of diabetic rats induced by intraperitoneal injection of streptozotocin (STZ) and the relationship between TRB3 expression and apoptosis and fibrosis were studied in this study.
research method
Eighty male Wistar rats aged 1.8 weeks were randomly divided into control group (30 rats) and diabetic group (50 rats). Diabetic rats were injected with STZ 60mg/kg body weight once intraperitoneally. The control group was injected with sodium citrate buffer intraperitoneally. Hematuria and urine of control group and DM group (7 rats in each group) were collected 8 weeks, 12 weeks, 16 weeks and 20 weeks after modeling. Kidney tissues were examined for each index. Blood glucose, 24-hour urinary protein and serum creatinine were detected by laboratory method; glomerular fibrosis was detected by PAS staining; the expressions of TRB3, fibronectin (FN) and Collagen I (Col I) were detected by immunohistochemical staining, fluorescence quantitative RT-PCR and Western blot. Diabetic rats were randomly divided into diabetes mellitus + blank virus group (DM + vehicle group) and diabetes mellitus + TRB3-siRNA group (DM + TRB3-siRNA group). Ten rats in each group were injected with blank virus and virus carrying TRB3-siRNA respectively. The kidneys were sacrificed after 4 weeks to detect the expression of TRB3, FN and Col I. Albumin stimulated and detected the expression of TRB3 and the secretion of FN and Collagen I. TRB3 was silenced by TRB3-siRNA and the secretion of FN and Col I was detected again to reveal the relationship between TRB3 and TRB3.
40 male Wistar rats aged 2.8 weeks were randomly divided into control group (control group), diabetes mellitus group (DM group), diabetes mellitus + vehicle group (DM + vehicle group) and diabetes mellitus + TRB3-siRNA virus group (DM + TRB3-siRNA group), 10 rats in each group. After 16 weeks, DM+vehicle group and DM+TRB3-siRNA group received tail vein injection of blank virus or virus carrying TRB3-siRNA respectively and were sacrificed 4 weeks later. The expression and apoptosis of TRB3 were detected in kidney tissues of rats. Renal tubular epithelial cells were cultured in vitro, and the expression and apoptosis of TRB3 were detected by albumin stimulation and T lymphocyte apoptosis. RB3-siRNA silenced TRB3 and detected apoptosis again to reveal the relationship between TRB3 and apoptosis, and further explore the role of Akt pathway in this process.
Result
1.TRB3 mediates accumulation of extracellular matrix in renal tubular cells in diabetic nephropathy
1.1 biochemical and histological changes
After STZ injection, the blood glucose, urinary protein excretion and serum creatinine clearance of diabetic rats were significantly increased, and the level of renal hypertrophy index were significantly higher than those of normal rats. PAS staining showed that the kidney of DN rats showed obvious deposition of extracellular matrix in mesangial area, and the level of glomerulosclerosis (GS) was higher than that of normal rats. Obviously increased.
Increased expression of 1.2TRB3 in kidneys of diabetic rats
Immunohistochemical staining showed that TRB3 was not expressed in the kidneys of the control group, but more TRB3-positive cells were found in the kidneys of DM rats. The expression of TRB3 mRNA in the kidneys of DM rats was significantly higher than that of the control group. Western blot showed that TRB3 protein was expressed in the control group. The amount was very low, but the expression increased significantly in diabetic group.
The expression of 1.3Col I and FN increased significantly in diabetic group, but decreased significantly after TRB3 silencing.
The results of immunohistochemistry and Western blot showed that the expression of Col I and FN increased significantly in diabetic group, but decreased significantly after TRB3 silencing.
1.4 albumin can induce NRK-52E cells to express TRB3..
1.5 albumin could induce NRK-52E cells to secrete Col I and FN, and TRB3 secreted and secreted less.
Detection of Col I and FN by ELISA showed that albumin increased the secretion of both, while TRB3-siRNA silenced the expression of TRB3 significantly decreased the secretion of both.
2.TRB3 mediates apoptosis of renal tubular epithelial cells in diabetic rats.
Increased expression of 2.1TRB3 in kidneys of diabetic rats
Immunohistochemical staining showed that TRB3 was not expressed in the kidneys of the control group, but more TRB3-positive cells were found in the kidneys of DM rats. The expression of TRB3 mRNA in the kidneys of DM rats was significantly higher than that of the control group. Western blot showed that TRB3 protein was expressed in the control group. The amount was very low, but the expression increased significantly in diabetic group.
2.2 the apoptosis of kidneys in diabetic rats and the effect of TRB3 silence on apoptosis.
In situ TUNEL assay showed that the number of positive cells in control group was very small, but the number of positive cells in DM group was significantly increased, and the positive cells were mainly located in renal tubular cells. The number of TUNEL-positive cells after TRB3-siRNA transfection was significantly lower than that after blank virus transfection. Caspase activity assay also proved this.
2.3 albumin can induce NRK-52E cells to express TRB3..
Albumin stimulated NRK-52E cells, and the expression of TRB3 increased with BSA concentration and stimulation time.
2.4 albumin can induce apoptosis of NRK-52E cells, while TRB3 silence can play a protective role.
The results of ssDNA-ELISA showed that the number of apoptotic cells increased significantly after albumin stimulation, but decreased significantly after TRB3 was silenced and then stimulated by albumin, which indicated that TRB3 mediated the process of apoptosis, and caspase activity also proved this.
2.5 Albumin induces apoptosis by blocking Akt phosphorylation, which can be partially reversed by TRB3 silencing.
Akt pathway is one of the main pathways regulating apoptosis. Albumin stimulation decreases phosphorylated Akt/Akt (p-Akt/Akt), and wortmannin blockades Akt phosphorylation, which indicates that Akt pathway does play a role in the process of apoptosis. After TRB3 silencing, p-Akt/Akt increases significantly, accompanied by apoptosis. The reduction indicates that Akt pathway plays a role in TRB3 induced apoptosis.
conclusion
1.TRB3 was upregulated in renal tubular cells of diabetic nephropathy.
2.TRB3 mediates the secretion of Collagen and FN in renal tubular extracellular matrix in diabetic nephropathy.
3.TPB3 mediates the apoptosis process of renal tubular cells in diabetic nephropathy.
4.TRB3 gene silencing can improve renal tubular cell apoptosis and extracellular matrix accumulation in diabetic nephropathy.
【学位授予单位】:山东大学
【学位级别】:博士
【学位授予年份】:2014
【分类号】:R587.2;R692.9

【相似文献】

相关期刊论文 前10条

1 黄列军,曹莜芬;糖尿病的主要危害是什么?[J];中国临床医生;2001年01期

2 梅晰凡,王伟;糖尿病足40例疗效观察[J];中国煤炭工业医学杂志;2001年04期

3 胡怀东,王玉君,庞久高;2型糖尿病患者尿Ⅳ型胶原与糖尿病肾病关系的研究[J];重庆医科大学学报;2001年01期

4 卢盛明,戴林,李爱萍;1例糖尿病并发严重多脏器功能障碍综合征患者治愈分析[J];中国危重病急救医学;2001年09期

5 姜醒,苑光军,马丽红;糖尿病的中医药治疗近况[J];中医药信息;2001年05期

6 孙德胜,肖萤;超声评价糖尿病肾病[J];中国医学影像技术;2001年01期

7 马为,郭泉滢,唐桂军;以糖肾安为主配合西药治疗糖尿病肾病60例[J];中医研究;2001年04期

8 翁小刚;中药治疗3例糖尿病肾病[J];国外医学(中医中药分册);2001年06期

9 周逸丹;;糖尿病饮食治疗现状[J];国外医学(老年医学分册);2001年02期

10 滕万同,杨莉;糖尿病性腹泻42例治疗体会[J];山东医药;2002年16期

相关会议论文 前10条

1 沙洪;肖诚;赵婷婷;郭景珍;黄小洁;王萍;李平;;糖尿病肾病的健康教育[A];中华中医药学会第二十一届全国中医肾病学术会议论文汇编(下)[C];2008年

2 杨丽平;李平;;糖尿病肾病合并贫血的相关发病机制[A];中华中医药学会第二十一届全国中医肾病学术会议论文汇编(下)[C];2008年

3 周海鸥;王黎芳;杨佳琦;钱大昕;陈士华;;社区糖尿病病人现状分析与对策[A];浙江省医学会医学微生物与免疫学及医学病毒学学术年会论文汇编[C];2009年

4 葛菲菲;;糖尿病肾病早期诊疗进展[A];第10届全国中西医结合肾脏病学术会议论文汇编[C];2009年

5 李桂芝;于道兰;;糖尿病肾病的饮食调理[A];中华护理学会全国第6届重症监护护理学术交流暨专题讲座会议论文汇编[C];2009年

6 金砾;;浅谈糖尿病的护理[A];第十四次全国中西医结合疡科学术交流会论文汇编[C];2009年

7 奚九一;;糖尿病足有二种坏死很难分辨,奚氏中医辨证可区别[A];中华中医药学会周围血管病分会2010年学术大会论文集[C];2010年

8 高继宁;赵怡蕊;李跃进;;糖尿病肾病的中西医结合治疗新进展[A];第十一届全国中西医结合肾脏病学术会议论文汇编[C];2010年

9 芦文娟;方敬爱;孙艳艳;张晓东;刘文媛;常沁涛;王蕊花;王月香;李慧;刘婷;;抗坏血酸与糖尿病肾病[A];第十一届全国中西医结合肾脏病学术会议论文汇编[C];2010年

10 简桂花;盛晓华;汪年松;;中西医结合治疗糖尿病肾病疗效观察[A];第十一届全国中西医结合肾脏病学术会议论文汇编[C];2010年

相关重要报纸文章 前10条

1 马明愈;现代生活方式导致 糖尿病发病率迅速上升[N];中国妇女报;2005年

2 主持人 向红丁博士;糖尿病肾病须早防早治[N];人民政协报;2002年

3 华悦;预防糖尿病,从减肥开始[N];上海中医药报;2004年

4 刘冬梅;肥胖糖尿病第一诱因[N];天津日报;2004年

5 李学燕;中药辅助治糖尿病肾病[N];健康时报;2007年

6 李旭红;中医帮您远离糖尿病[N];市场报;2007年

7 吕洋;糖尿病患者警惕血管病变[N];卫生与生活报;2007年

8 记者 崔昕;中药早期防治糖尿病肾病取得突破性进展[N];中国医药报;2006年

9 崔昕;《糖尿病中医防治指南》发布[N];中国医药报;2007年

10 记者 周颖邋高新军;防治糖尿病首部中医指南发布[N];中国中医药报;2007年

相关博士学位论文 前10条

1 尹士男;40岁以下发病2型糖尿病患者的临床和分子遗传学特点初步分析[D];中国人民解放军军医进修学院;2002年

2 职心乐;天津市2型糖尿病及其并发症患病率调查及相关危险因素研究[D];天津医科大学;2007年

3 付文金;尿液组织因子促凝活性检测方法的建立及其在糖尿病肾病中的应用研究[D];南方医科大学;2011年

4 孙晓泽;中医辨证治疗早期和临床期糖尿病肾病的临床研究[D];广州中医药大学;2011年

5 苑迅;糖肾康治疗糖尿病肾病机理研究[D];黑龙江中医药大学;2002年

6 李伟华;澳门与广州地区2型糖尿病中医证型特点比较与探讨[D];广州中医药大学;2012年

7 王俊杰;香港地区2型糖尿病的中医证型特点[D];广州中医药大学;2012年

8 徐亚兰;2型糖尿病肾脏损害与糖尿病视网膜病变相关性的临床和病理研究[D];中国协和医科大学;2008年

9 丁丹;胃肠外科手术治疗糖尿病血清蛋白质组学研究[D];第二军医大学;2011年

10 郭茂田;中西医结合诊治糖尿病的现状及发展前景[D];南京中医药大学;2004年

相关硕士学位论文 前10条

1 张双;糖尿病伴发贫血的影响因素分析[D];浙江大学;2009年

2 李燕玲;双重糖尿病临床特征的探讨[D];中南大学;2009年

3 孙永胜;2型糖尿病肾病临床调查分析[D];遵义医学院;2009年

4 吴楠;2型糖尿病住院患者慢性肾脏病诊断方法初探[D];复旦大学;2010年

5 苏丽丽;尿液的表面增强拉曼光谱检测用于糖尿病的研究[D];大连理工大学;2011年

6 肖憬;2型糖尿病肾病患者白介素-8、白介素-10的变化及临床意义[D];兰州大学;2011年

7 黎雅清;2型糖尿病患者心率变异度与糖尿病肾病的关系[D];暨南大学;2005年

8 卜彦屏;糖尿病足危险因素探讨[D];天津医科大学;2002年

9 陈宽林;血清转化生长因子β_1与2型糖尿病肾病相关性临床研究[D];福建医科大学;2002年

10 马文革;社区2型糖尿病患者治疗行为调查及健康教育干预效果研究[D];安徽医科大学;2004年



本文编号:2178322

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/mjlw/2178322.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户7f314***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com